Abstract

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1

Author(s): Williams LaVonn

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 284-287

Download in electronic PDF format for $75
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Page 1
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Page 2
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Page 3
  • The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1 Page 4

Abstract

Gout, a common and complex form of inflammatory arthritis, is characterized by abnormally elevated levels of uric acid in the blood. It is estimated that 52.5 million people in the U.S. have arthritis or one of the rheumatic diseases, according to the Centers for Disease Control and Prevention. There are over 100 rheumatic diseases and conditions. In the U.S., the most common types of arthritis or rheumatic diseases are osteoarthritis, gout, fibromyalgia, and rheumatoid arthritis, in that order according to prevalence. This article focuses on gout. Although there is no cure for gout, the disease can be effectively treated and managed with a combination of medication (manufactured and/or compounded) and self-management strategies.

Related Keywords

  • gout
  • inflammatory arthritis
  • rheumatic disorders
  • uric acid
  • hyperuricemia
  • dietary purines
  • joint pain
  • tophi
  • sodium urate monohydrate crystals
  • extremities
  • hands
  • feet
  • podagra
  • history
  • water activity
  • bacteria
  • molds
  • fungi
  • microbial contamination
  • free water
  • microorganisms
  • foods
  • excipients
  • storage temperature
  • instruments
  • hygrometer
  • United States Pharmacopeia Chapter <1112> Application of Water Activity Determination to Nonsterile Pharmaceutical Products
  • USP
  • degradation
  • chemical hydrolysis
  • self-preservation
  • preservatives
  • microbial limit testing

Related Categories

  • HISTORY
  • PAIN MANAGEMENT
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2018
Pg. 284-287
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Author(s): Williams LaVonn
Jan/Feb 2019
Pg. 14-21
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Author(s): Williams LaVonn A
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn
Nov/Dec 2003
Pg. 426-435
View Sample
Sore Nipples in Breastfeeding Mothers: Causes and Treatments
Author(s): Albright Lisa M
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 498-504
Case Reports: Compounding to Relieve Arthritis Pain
Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 125-132
A Concise Discussion of Headache Types, Part 1
Author(s): Williams LaVonn A
Jul/Aug 2013
Pg. 328
Allopurinol Sodium 4-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jul/Aug 2012
Pg. 270-274
A Concise Discussion of Headache Types, Part 3: Migraine
Author(s): Williams LaVonn A, Allen Loyd V Jr
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael
Jan/Feb 2014
Pg. 14-19
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Author(s): Zur Eyal
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso